Science New Advances in NSCLC Biomarker Testing Transform Treatment Landscape The field of biomarker testing for non-small cell lung cancer (NSCLC) is evolving, with a shift from traditional genomic markers to a new emphasis... Editorial15 November, 2025
Science Navigating Therapy Options for Relapsed Multiple Myeloma Patients The treatment landscape for patients with relapsed multiple myeloma is evolving, with the introduction of therapies such as CAR T, bispecific antibodies, and antibody-drug... Editorial25 July, 2025